Breakfast Brief Dr. Pall – Related Abstracts
Breakfast Brief Dr. Pall – Related Abstracts In the third Breakfast Brief, Dr. Georg Pall presented the following abstracts: Long-term outcomes in patients (pts) with ipilimumab (ipi)-naive advanced melanoma in the phase 3 KEYNOTE-006 study who completed pembrolizumab (pembro) treatment. Results: A total of 222 pts were randomly assigned (Sep 19 2011 to Apr 24 2014).
Um das Video zu sehen, müssen Sie sich einloggen oder kostenlos registrieren.
More from this topic: